Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06495190 · ClinicalTrials.gov registry record · NA

Cognition, Flavonoids, Exercise, Gut Microbiome

A NA study of Cognitive Decline, Mild, sponsored by Appalachian State University.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
1
Study location

NCT06495190 is a NA study of Cognitive Decline, Mild that is actively recruiting participants, run by Appalachian State University. The registered enrollment target is 240 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06495190, a NA study of Cognitive Decline, Mild, is actively recruiting participants, sponsored by Appalachian State University.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

This NIH project will examine the effects of routine flavonoid-rich blueberry intake (12-weeks), combined with or in the absence of regular moderate exercise, on cognitive function in a clinical population of older participants identified as experiencing age-related cognitive changes. This project's hypothesis is that the combination of flavonoid-rich diet and routine physical activity may potentiate cognitive benefits and reduce cognitive decline in an aging population, via mechanisms mediated by the gut microbiome.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • BEHAVIORAL Stretching
  • BEHAVIORAL Walking
  • DIETARY_SUPPLEMENT Blueberry

Study Locations (1)

North Carolina

  • Appalachian State University Human Performance Lab, North Carolina Research Campus - Kannapolis

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2025-01-01
Est. Completion 2028-12-31
Phase NA

Sponsor

Appalachian State University

37 total trials

What the Registry Record Tells You About NCT06495190

The ClinicalTrials.gov registry entry for NCT06495190 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Appalachian State University, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cognitive Decline, Mild appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.

NCT06495190 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06495190 about?

NCT06495190 is a clinical study titled "Cognition, Flavonoids, Exercise, Gut Microbiome". This NIH project will examine the effects of routine flavonoid-rich blueberry intake (12-weeks), combined with or in the absence of regular moderate exercise, on cognitive function in a clinical population of older participants identified as experiencing age-related cognitive changes. This project's...

What is the current status of trial NCT06495190?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2025-01-01. Estimated completion is 2028-12-31.

What conditions does trial NCT06495190 study?

This clinical trial studies the following conditions: Cognitive Decline, Mild.

What interventions are being tested in trial NCT06495190?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Stretching (BEHAVIORAL), Walking (BEHAVIORAL), Blueberry (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06495190?

This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06495190 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.